Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
Contact Us
Versions and log file
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
LUCANTHONE HYDROCHLORIDE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
LUCANTHONE HYDROCHLORIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
918K9N56QZ
Molecule Type:
Small molecule
Molecular Formula:
C20H25ClN2OS
Molecular Weight:
376.95
AlogP:
4.48
PSA:
32.34
HBD:
1.0
HBA:
#RotB:
6.0
Source:
FIPAXALPARANT
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
FIPAXALPARANT
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SERALUTINIB
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
SERALUTINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
3P63ZTE3OY
Molecule Type:
Small molecule
Molecular Formula:
C27H27N5O3
Molecular Weight:
469.55
AlogP:
5.29
PSA:
98.26
HBD:
2.0
HBA:
#RotB:
8.0
Source:
DP001
(2)
Small molecule
Vitamin D receptor agonist
Unknown
Investigational
Unknown
DP001
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C27H44O3
Molecular Weight:
416.65
AlogP:
5.7
PSA:
60.69
HBD:
3.0
HBA:
#RotB:
6.0
Source:
AMA0076
(2)
Small molecule
Rho-associated protein kinase inhibitor
Unknown
Investigational
Unknown
AMA0076
×
Maximum Phase:
2
First Approval:
None
UNII:
C23O3R93BM
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PYROPHOSPHORIC ACID
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
PYROPHOSPHORIC ACID
×
Maximum Phase:
2
First Approval:
None
UNII:
4E862E7GRQ
Molecule Type:
Small molecule
Molecular Formula:
H4O7P2
Molecular Weight:
177.97
AlogP:
-0.81
PSA:
124.29
HBD:
4.0
HBA:
#RotB:
2.0
Source:
MITOQUINONE CATION
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
MITOQUINONE CATION
×
Maximum Phase:
2
First Approval:
None
UNII:
47BYS17IY0
Molecule Type:
Small molecule
Molecular Formula:
C37H44O4P+
Molecular Weight:
583.73
AlogP:
7.46
PSA:
52.6
HBD:
0.0
HBA:
#RotB:
16.0
Source:
ROBALZOTAN
(2)
Small molecule
Serotonin 1a (5-HT1a) receptor antagonist
Unknown
Investigational
Unknown
ROBALZOTAN
×
Maximum Phase:
2
First Approval:
None
UNII:
I18M56OGME
Molecule Type:
Small molecule
Molecular Formula:
C18H23FN2O2
Molecular Weight:
318.39
AlogP:
2.64
PSA:
55.56
HBD:
1.0
HBA:
#RotB:
4.0
Source:
PX-102
(2)
Small molecule
Bile acid receptor FXR agonist
Unknown
Investigational
Unknown
PX-102
×
Maximum Phase:
2
First Approval:
None
UNII:
378SU5NO8S
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BMS-223131
(2)
Small molecule
Calcium-activated potassium channel subunit alpha-1 activator
Unknown
Investigational
Unknown
BMS-223131
×
Maximum Phase:
2
First Approval:
None
UNII:
889F719S7K
Molecule Type:
Small molecule
Molecular Formula:
C18H13ClF3NO3
Molecular Weight:
383.75
AlogP:
4.11
PSA:
73.32
HBD:
3.0
HBA:
#RotB:
3.0
Source:
ORVEPITANT
(2)
Small molecule
Neurokinin 1 receptor antagonist
Unknown
Investigational
Unknown
ORVEPITANT
×
Maximum Phase:
2
First Approval:
None
UNII:
IIU6V0W3JD
Molecule Type:
Small molecule
Molecular Formula:
C31H35F7N4O2
Molecular Weight:
628.63
AlogP:
6.8
PSA:
47.1
HBD:
0.0
HBA:
#RotB:
4.0
Source:
D-ASPARTATE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
D-ASPARTATE
×
Maximum Phase:
2
First Approval:
None
UNII:
4SR0Q8YD1X
Molecule Type:
Small molecule
Molecular Formula:
C4H7NO4
Molecular Weight:
133.1
AlogP:
-1.13
PSA:
100.62
HBD:
3.0
HBA:
#RotB:
3.0
Source:
BAFETINIB
(2)
Small molecule
Tyrosine-protein kinase ABL inhibitor
Unknown
Investigational
Unknown
BAFETINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
NVW4Z03I9B
Molecule Type:
Small molecule
Molecular Formula:
C30H31F3N8O
Molecular Weight:
576.63
AlogP:
5.39
PSA:
99.17
HBD:
2.0
HBA:
#RotB:
8.0
Source:
THK-5351
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
THK-5351
×
Maximum Phase:
2
First Approval:
None
UNII:
JE3F6WUN31
Molecule Type:
Small molecule
Molecular Formula:
C18H18FN3O2
Molecular Weight:
327.36
AlogP:
3.05
PSA:
67.27
HBD:
2.0
HBA:
#RotB:
6.0
Source:
DOLASTATIN-10
(2)
Small molecule
Tubulin inhibitor
Unknown
Investigational
Unknown
DOLASTATIN-10
×
Maximum Phase:
2
First Approval:
None
UNII:
EI946JT51X
Molecule Type:
Small molecule
Molecular Formula:
C42H68N6O6S
Molecular Weight:
785.11
AlogP:
5.19
PSA:
133.41
HBD:
2.0
HBA:
#RotB:
21.0
Source:
TRETAZICAR
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
TRETAZICAR
×
Maximum Phase:
2
First Approval:
None
UNII:
7865D5D01M
Molecule Type:
Small molecule
Molecular Formula:
C9H8N4O5
Molecular Weight:
252.19
AlogP:
0.42
PSA:
132.38
HBD:
1.0
HBA:
#RotB:
4.0
Source:
CE-224535
(2)
Small molecule
P2X purinoceptor 7 antagonist
Unknown
Investigational
Unknown
CE-224535
×
Maximum Phase:
2
First Approval:
None
UNII:
T8B02RAU3C
Molecule Type:
Small molecule
Molecular Formula:
C22H29ClN4O6
Molecular Weight:
480.95
AlogP:
0.87
PSA:
135.68
HBD:
3.0
HBA:
#RotB:
8.0
Source:
TINLORAFENIB
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
TINLORAFENIB
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LUVIXASERTIB
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
LUVIXASERTIB
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ETILEVODOPA
(2)
Small molecule
Dopamine D3 receptor agonist
Unknown
Investigational
Unknown
ETILEVODOPA
×
Maximum Phase:
2
First Approval:
None
UNII:
895X917GYE
Molecule Type:
Small molecule
Molecular Formula:
C11H15NO4
Molecular Weight:
225.24
AlogP:
0.53
PSA:
92.78
HBD:
3.0
HBA:
#RotB:
4.0
Source:
VESTIPITANT
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
VESTIPITANT
×
Maximum Phase:
2
First Approval:
None
UNII:
S052TOI9BI
Molecule Type:
Small molecule
Molecular Formula:
C23H24F7N3O
Molecular Weight:
491.45
AlogP:
5.93
PSA:
35.58
HBD:
1.0
HBA:
#RotB:
3.0
Source:
ODIPARCIL
(2)
Small molecule
Glycosaminoglycans modulator
Unknown
Investigational
Unknown
ODIPARCIL
×
Maximum Phase:
2
First Approval:
None
UNII:
FIK1414ZI8
Molecule Type:
Small molecule
Molecular Formula:
C15H16O6S
Molecular Weight:
324.35
AlogP:
0.64
PSA:
100.13
HBD:
3.0
HBA:
#RotB:
2.0
Source:
TELATINIB
(2)
Small molecule
Platelet-derived growth factor receptor beta inhibitor
Unknown
Investigational
Unknown
TELATINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
18P7197Q7J
Molecule Type:
Small molecule
Molecular Formula:
C20H16ClN5O3
Molecular Weight:
409.83
AlogP:
3.95
PSA:
102.17
HBD:
2.0
HBA:
#RotB:
6.0
Source:
CNV2197944
(2)
Small molecule
Voltage-gated N-type calcium channel alpha-1B subunit blocker
Unknown
Investigational
Unknown
CNV2197944
×
Maximum Phase:
2
First Approval:
None
UNII:
SSB9S6N20R
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FLORZOLOTAU
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
FLORZOLOTAU
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ALOVUDINE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
ALOVUDINE
×
Maximum Phase:
2
First Approval:
None
UNII:
PG53R0DWDQ
Molecule Type:
Small molecule
Molecular Formula:
C10H13FN2O4
Molecular Weight:
244.22
AlogP:
-0.54
PSA:
84.32
HBD:
2.0
HBA:
#RotB:
2.0
Source:
2-HYDROXYOLEIC ACID
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
2-HYDROXYOLEIC ACID
×
Maximum Phase:
2
First Approval:
None
UNII:
OSV3KVO1BT
Molecule Type:
Small molecule
Molecular Formula:
C18H34O3
Molecular Weight:
298.47
AlogP:
5.08
PSA:
57.53
HBD:
2.0
HBA:
#RotB:
15.0
Source:
MERICITABINE
(2)
Small molecule
Hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitor
Unknown
Investigational
Unknown
MERICITABINE
×
Maximum Phase:
2
First Approval:
None
UNII:
TA63JX8X52
Molecule Type:
Small molecule
Molecular Formula:
C18H26FN3O6
Molecular Weight:
399.42
AlogP:
1.22
PSA:
122.74
HBD:
1.0
HBA:
#RotB:
6.0
Source:
LB-100
(2)
Small molecule
Serine/threonine protein phosphatase 2A, catalytic subunit, alpha isoform inhibitor
Unknown
Investigational
Unknown
LB-100
×
Maximum Phase:
2
First Approval:
None
UNII:
0C1JUU9S0L
Molecule Type:
Small molecule
Molecular Formula:
C13H20N2O4
Molecular Weight:
268.31
AlogP:
-0.36
PSA:
70.08
HBD:
1.0
HBA:
#RotB:
2.0
Source:
SODIUM TUNGSTATE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
SODIUM TUNGSTATE
×
Maximum Phase:
2
First Approval:
None
UNII:
64LRH4405G
Molecule Type:
Small molecule
Molecular Formula:
Na2O4W
Molecular Weight:
293.82
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
INDIRUBIN
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
INDIRUBIN
×
Maximum Phase:
2
First Approval:
None
UNII:
V86L8P74GI
Molecule Type:
Small molecule
Molecular Formula:
C16H10N2O2
Molecular Weight:
262.27
AlogP:
2.66
PSA:
58.2
HBD:
2.0
HBA:
#RotB:
0.0
Source:
TEMANOGREL
(2)
Small molecule
Serotonin 2a (5-HT2a) receptor inverse agonist
Unknown
Investigational
Unknown
TEMANOGREL
×
Maximum Phase:
2
First Approval:
None
UNII:
F42Z27575A
Molecule Type:
Small molecule
Molecular Formula:
C24H28N4O4
Molecular Weight:
436.51
AlogP:
3.06
PSA:
77.85
HBD:
1.0
HBA:
#RotB:
8.0
Source:
VALILOXYBATE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
VALILOXYBATE
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
METHYLSAMIDORPHAN
(2)
Small molecule
Mu opioid receptor antagonist
Unknown
Investigational
Unknown
METHYLSAMIDORPHAN
×
Maximum Phase:
2
First Approval:
None
UNII:
8347HC35J6
Molecule Type:
Small molecule
Molecular Formula:
C22H29N2O4+
Molecular Weight:
385.48
AlogP:
1.4
PSA:
100.62
HBD:
3.0
HBA:
#RotB:
3.0
Source:
OLODANRIGAN
(2)
Small molecule
Angiotensin II type 2 (AT-2) receptor antagonist
Unknown
Investigational
Unknown
OLODANRIGAN
×
Maximum Phase:
2
First Approval:
None
UNII:
P0FN522VTO
Molecule Type:
Small molecule
Molecular Formula:
C32H29NO5
Molecular Weight:
507.59
AlogP:
5.44
PSA:
76.07
HBD:
1.0
HBA:
#RotB:
8.0
Source:
SRX246
(2)
Small molecule
Vasopressin V1a receptor antagonist
Unknown
Investigational
Unknown
SRX246
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C43H48F3N5O5
Molecular Weight:
771.88
AlogP:
6.6
PSA:
102.5
HBD:
1.0
HBA:
#RotB:
11.0
Source:
1
2
…
148
149
150
151
152
153
154
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA